Skip to main content

AdaptHealth Corp. (AHCO)

NASDAQ: AHCO · IEX Real-Time Price · USD
7.29
-0.03 (-0.41%)
Dec 29, 2023, 4:00 PM EST - Market closed

AdaptHealth Revenue

AdaptHealth had revenue of $3.12B in the twelve months ending September 30, 2023, with 7.95% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $804.03M with 6.28% year-over-year growth. In the year 2022, AdaptHealth had annual revenue of $2.97B with 21.02% growth.

Revenue (ttm)
$3.12B
Revenue Growth
+7.95%
P/S Ratio
0.32
Revenue / Employee
$286,443
Employees
10,900
Market Cap
994.28M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20222.97B516.06M
21.02%
Dec 31, 20212.45B1.40B
132.35%
Dec 31, 20201.06B526.75M
99.45%
Dec 31, 2019529.64M-176.69M
-25.01%
Dec 31, 2018706.33M513.77M
266.81%
Dec 31, 2017192.56M18.24M
10.47%
Dec 31, 2016174.32M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Collegium Pharmaceutical 546.64M
MiMedx Group 309.02M
Amylyx Pharmaceuticals 294.22M
ADMA Biologics 234.29M
MannKind 176.55M
National Research 148.72M
Tango Therapeutics 37.51M
Revenue Rankings

AHCO News

More News